Harvard

The Society for Cardiovascular Angiography and Interventions announced its 2022 Master Interventionalists of SCAI designations, which will be formally recognized during the SCAI Scientific Sessions in Atlanta on May 21, 2022.

A substantial proportion of patients with resected early non-small cell lung cancer who consented to an adjuvant therapy screening trial did not receive adequate lymph node dissection or adjuvant chemotherapy, according to study results.

Adults with diabetes in the U.S. are more likely to have dental caries and a higher mean number of missing teeth compared with those without diabetes, according to study findings published in Diabetic Medicine.

In this episode, Amy Comander, MD, Beth Frates, MD, and Michelle Tollefson, MD, discuss their journeys in the breast cancer treatment and awareness space and their new personal well-being resource, PAVING the Path to Wellness Workbook.

BOSTON — The keynote speaker at the National Kidney Foundation Spring Clinical Meetings discussed racial disparities in the United States and how physicians can change their practices and political behavior to achieve health equity.

Rilzabrutinib induced rapid and durable clinical activity in previously treated patients with immune thrombocytopenia, according to results of a phase 1/phase 2 clinical trial published in The New England Journal of Medicine.

Metabolite profiles demonstrate that eating a healthy plant-based diet rich in whole grains, fruits, vegetables and nuts can lower one’s risk for developing type 2 diabetes, according to study findings published in Diabetologia.

BOSTON — New research presented during the late-breaking trials program at the National Kidney Foundation Spring Clinical Meetings showed the anemia drug daprodustat has cardiovascular benefits comparable to erythropoiesis-stimulating agents.

An artificial intelligence model showed potential for pancreatic cancer prediction, using electronic medical records to identify individuals with a 25-fold greater risk for developing the disease within 3 to 36 months, study results showed.

Two servings of avocado per week, compared with not eating any avocado, was associated with lower risk for CVD and CHD, but not stroke, researchers reported.